William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 20,777 shares at $55.00 ($1.1M) on 2023-06-20, disclosed to the SEC on 2023-06-22.
Open-market sale of $1.1M AKRO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |